Keith A. Goldan
Chief Financial Officer · Syndax Pharmaceuticals Inc
- 2025
- Jun 2, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Keith A. Goldan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Vishwas Seshadri - $1.51M in ABEO purchases and sales in the last 12 months
- Michael A. Metzger - $1.43M in SNDX purchases and sales in the last 12 months
- Nicholas A.J. Botwood - $1.18M in SNDX purchases and sales in the last 12 months
- Joseph Walter Vazzano - $599K in ABEO purchases and sales in the last 12 months
- Mark Alvino - $275K in ABEO purchases and sales in the last 12 months
- Madhav Vasanthavada - $264K in ABEO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Keith A. Goldan?
Keith A. Goldan is a corporate insider, tracked as Chief Financial Officer of Syndax Pharmaceuticals Inc (SNDX). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Keith A. Goldan last file a Form 4?
The most recent primary Form 4 on record is dated 2 June 2026, one of 7 filings going back to 2025.
Has Keith A. Goldan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($149K) across all tracked filings.
